Showing results (1771-1780 of 2,758) with videos related to
Sort By:
Pageof 276
Heart (British Cardiac Society)|February 23, 1999
Effect of coronary occlusion on left ventricular function with and without collateral supply during beating heart coronary artery surgeryT W Koh, G S Carr-White, A C DeSouza, et al.International Journal of Cancer|December 10, 1999
Elevated levels of angiogenic cytokines in the plasma of cancer patientsE Fuhrmann-Benzakein, M N Ma, L Rubbia-Brandt, et al.Endocrinology|November 1, 1993
Differential expression of gap junction connexins in endocrine and exocrine glandsP Meda, M S Pepper, O Traub, et al.Journal of Leukocyte Biology|August 1, 1996
Expansion of the gammadelta T cell subset in vivo during bloodstage malaria in B cell-deficient miceH C van der Heyde, M M Elloso, W L Chang, et al.The American Journal of Pathology|June 25, 2004
Generation and characterization of telomerase-transfected human lymphatic endothelial cells with an extended life spanRiccardo E Nisato, Jillian A Harrison, Raphaele Buser, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 14, 2006
Lentiviral vector transduction of a dominant-negative Rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replicationIngrid Bahner, Teiko Sumiyoshi, Mercy Kagoda, et al.Transplantation|July 1, 1990
Noninvasive monitoring of human cardiac allograft rejectionJ A Reader, M M Burke, P Counihan, et al.Journal of Dairy Science|December 3, 2013
Improved performance and heightened neutrophil responses during the neonatal and weaning periods among outdoor group-housed Holstein calvesC J Cobb, B S Obeidat, M D Sellers, et al.Molecular Carcinogenesis|March 6, 2020
Loss of myoepithelial calponin-1 characterizes high-risk ductal carcinoma in situ cases, which are further stratified by T cell compositionElizabeth Mitchell, Sonali Jindal, Tiffany Chan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2009
Rel a is an independent biomarker of clinical outcome in chronic lymphocytic leukemiaSaman Hewamana, Thet Thet Lin, Clare Rowntree, et al.Pageof 276